ESC Premium Access

Performance of a multisensory implantable cardioverter-defibrillator algorithm for remote heart failure management: the RE-HEART registry

Congress Session

About the speaker

Doctor Javier De Juan Baguda

University Hospital 12 de Octubre, Madrid (Spain)
2 presentations
0 follower

11 more presentations in this session

The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?

Speaker: Doctor J. Borges-Rosa (Coimbra, PT)

Thumbnail

Telerobotic interventions from a distance: an initial experience in 3D phantom mapping

Speaker: Doctor S. Ailoaei (Iasi, RO)

Thumbnail

A comparison of over-the-counter available smartwatches and devices for electrocardiogram based detection of atrial fibrillation

Speaker: Ms J. Scholten (Amsterdam, NL)

Thumbnail

Investigating performance of deep learning and machine learning risk stratification of Asian in-hospital patients after ST-elevation myocardial infarction.

Speaker: Doctor K. Ibrahim (Sungai Buloh, MY)

Thumbnail

Inter operator variability of machine learning researchers predicting all-cause mortality in patients admitted to intensive care unit

Speaker: Miss Y. Jones (Glasgow, GB)

Thumbnail

Access the full session

Congress committee e-posters choice in e-cardiology and digital health

Speakers: Doctor J. De Juan Baguda, Doctor J. Borges-Rosa, Doctor S. Ailoaei, Ms J. Scholten, Doctor K. Ibrahim...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes

27 August 2021

ESC Premium Access

Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis

27 August 2021

ESC Premium Access

Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial

27 August 2021

This platform is supported by

logo Novo Nordisk